LDHA/PDKs-IN-2 structure
|
Common Name | LDHA/PDKs-IN-2 | ||
|---|---|---|---|---|
| CAS Number | 2490699-44-8 | Molecular Weight | 332.35 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H20N2O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LDHA/PDKs-IN-2LDHA/PDKs-IN-2 (compound 20k) is a potent and dual inhibitor of PDKs and LDHA with IC50s of 1.6 and 0.7 μM, respectively. LDHA/PDKs-IN-2 reduces A549 cell proliferation with an EC50 of 15.7 μM and decreases the lactate formation, and increases oxygen consumption. LDHA/PDKs-IN-2 has the potential for the research of cancer diseases[1]. |
| Name | LDHA/PDKs-IN-2 |
|---|
| Description | LDHA/PDKs-IN-2 (compound 20k) is a potent and dual inhibitor of PDKs and LDHA with IC50s of 1.6 and 0.7 μM, respectively. LDHA/PDKs-IN-2 reduces A549 cell proliferation with an EC50 of 15.7 μM and decreases the lactate formation, and increases oxygen consumption. LDHA/PDKs-IN-2 has the potential for the research of cancer diseases[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C17H20N2O5 |
|---|---|
| Molecular Weight | 332.35 |